57028-27-0Relevant articles and documents
Electrophilicity of a 9-aryl-9-fluorenyl cation in water - Kinetic evidence for antiaromaticity
Ward, Sarah,Messier, Tammy,Lukeman, Matthew
, p. 493 - 499 (2010)
The 9-(4-methoxyphenyl)-9-fluorenyl cation (2) has been generated in 100% water by laser flash photolysis of 9-(4-methoxyphenyl)-9-fluorenol (3), representing the first observation of a 9-fluorenyl cation in this solvent with lifetimes in the microsecond
Spiro[fluorene-9,9′-xanthene]-based universal hosts for understanding structure-property relationships in RGB and white PhOLEDs
Qian, Yan,Ni, Yeren,Yue, Shouzhen,Li, Wenwen,Chen, Shufen,Zhang, Zhensong,Xie, Linghai,Sun, Mingli,Zhao, Yi,Huang, Wei
, p. 29828 - 29836 (2015/05/13)
Ingenious construction of state-of-the-art models of electrophosphorescent hosts for uncovering the deep role of different molecular modifications in PhOLEDs performances is crucial for rational cumulative improvements of device efficiency and for acceler
Tricylic amino-acid derivatives
-
, (2008/06/13)
Described herein are compounds which have the general formula: or a prodrug or pharmaceutically acceptable salt, solvate or hydrate thereof wherein: R1 is selected from the group consisting of H, alkyl and the counter ion for a basic addition salt; X is selected from the group consisting of CR9R10, S, O, SO, SO2, NH and N-alkyl; R2, R3, R4, R9 and R10 are independently selected from the group consisting of H and alkyl; R5 and R6 are independently selected from the group consisting of H, alkyl and phenyl, or, alternatively, R5 and R6 together may form a methylene group or a 3- to 6-membered a spirocyclic group; wherein, when X is CR9R10, one or both pairs of R5 and R9 or R6 and R10 may join to form a double or triple bond R7 is selected from the group consisting of Formula II-V: which are all optionally substituted, at nodes other than R8, with 1-4 substituents independently selected from the group consisting of alkyl, halo, aryl (which may be substituted as for R8), trifluoromethyl, trifluoromethoxy, nitro, cyano, amino, mono-alkylamino, di-alkylamino, alkoxycarbonyl, alkylcarbonyl, alkoxythiocarbonyl, alkylthiocarbonyl, alkoxy, alkylS-, phenoxy, -SO2NH2, -SO2NHalkyl, -SO2N(alkyl)2 and 1,2-methylenedioxy; and wherein any of the benzo-fused rings in structures II to V may be replaced by a 5- or 6-membered heterocyclic ring selected from the group consisting of pyridine, thiophene, furan and pyrrole; wherein R8 is selected from the group consisting of H, alkyl, benzyl, cycloalkyl, indanyl and an optionally substituted aryl group, wherein the optional substituents are independently selected from 1-4 members of the group consisting of alkyl, halo, aryl, trifluoromethyl, trifluoromethoxy, nitro, cyano, amino, mono-alkylamino, di-alkylamino, alkoxycarbonyl, alkylcarbonyl, alkoxythiocarbonyl, alkylthiocarbonyl, alkoxy, alkylS-, phenoxy, -SO2NH2, -SO2NHalkyl, -SO2N(alkyl)2 and 1,2-methylenedioxy; -represents a single or double bond; Y is selected from the group consisting of O, S, SO, NH, N-alkyl, CH2, CH-alkyl, C(alkyl)2, and C=O; Z is selected from the group consisting of CH2, O, S, NH and N-alkyl when-is a single bond; Z is selected from the group consisting of CH and N when-is a double bond. Also described is the use of these compounds as pharmaceuticals.
